HEADER LIPID-BINDING PROTEIN 17-NOV-08 2W3Y TITLE STRUCTURE OF THE EVF VIRULENCE FACTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: VIRULENCE FACTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: EVF; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PECTOBACTERIUM CAROTOVORUM SUBSP. SOURCE 3 CAROTOVORUM; SOURCE 4 ORGANISM_TAXID: 555; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21-GOLD(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET9 KEYWDS DROSOPHILA PATHOGEN, ERWINIA CAROTOVORA, S-PALMITOYLATED KEYWDS 2 PROTEIN, LIPID-BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.QUEVILLON-CHERUEL,N.LEULLIOT,C.ACOSTA MUNIZ C,M.VINCENT, AUTHOR 2 J.GALLAY,M.ARGENTINI,D.CORNU,F.BOCCARD,B.LEMAITRE, AUTHOR 3 H.VAN TILBEURGH REVDAT 2 20-APR-11 2W3Y 1 JRNL REMARK DBREF SEQADV REVDAT 2 2 FORMUL HETATM REVDAT 1 30-DEC-08 2W3Y 0 JRNL AUTH S.QUEVILLON-CHERUEL,N.LEULLIOT,C.ACOSTA MUNIZ, JRNL AUTH 2 M.VINCENT,J.GALLAY,M.ARGENTINI,D.CORNU,F.BOCCARD, JRNL AUTH 3 B.LEMAITRE,H.VAN TILBEURGH JRNL TITL EVF, A VIRULENCE FACTOR PRODUCED BY THE DROSOPHILA JRNL TITL 2 PATHOGEN ERWINIA CAROTOVORA IS A S-PALMITOYLATED JRNL TITL 3 PROTEIN WITH A NEW FOLD THAT BINDS TO LIPID VESICLES. JRNL REF J.BIOL.CHEM. V. 284 3552 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 18978353 JRNL DOI 10.1074/JBC.M808334200 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 62.87 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 36142 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1900 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2611 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2730 REMARK 3 BIN FREE R VALUE SET COUNT : 142 REMARK 3 BIN FREE R VALUE : 0.3940 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4247 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 362 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.22000 REMARK 3 B22 (A**2) : -0.11000 REMARK 3 B33 (A**2) : -0.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.209 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.182 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.134 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.721 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4380 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5903 ; 1.179 ; 1.932 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 524 ; 5.845 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 233 ;39.498 ;25.451 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 721 ;14.861 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;23.578 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 618 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3387 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1785 ; 0.188 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2986 ; 0.298 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 304 ; 0.131 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 48 ; 0.151 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.113 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2691 ; 0.706 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4205 ; 1.197 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1926 ; 1.754 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1698 ; 2.713 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2W3Y COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-NOV-08. REMARK 100 THE PDBE ID CODE IS EBI-38141. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9798 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38113 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.00 REMARK 200 RESOLUTION RANGE LOW (A) : 80.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 27.7 REMARK 200 R MERGE (I) : 0.10 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.60 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG4000, 50MM BICINE PH 8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.78000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.72850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.35750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.72850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.78000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.35750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LEU A 2 REMARK 465 ASN A 3 REMARK 465 GLU A 4 REMARK 465 LYS A 5 REMARK 465 ALA A 6 REMARK 465 ILE A 7 REMARK 465 PRO A 20 REMARK 465 GLU A 21 REMARK 465 GLY A 22 REMARK 465 HIS A 278 REMARK 465 HIS A 279 REMARK 465 HIS A 280 REMARK 465 HIS A 281 REMARK 465 HIS A 282 REMARK 465 HIS A 283 REMARK 465 MET B 1 REMARK 465 LEU B 2 REMARK 465 ASN B 3 REMARK 465 GLU B 4 REMARK 465 LYS B 5 REMARK 465 ALA B 6 REMARK 465 ILE B 7 REMARK 465 GLN B 8 REMARK 465 ASP B 9 REMARK 465 PRO B 20 REMARK 465 GLU B 21 REMARK 465 GLY B 22 REMARK 465 ARG B 23 REMARK 465 LEU B 24 REMARK 465 ALA B 25 REMARK 465 SER B 26 REMARK 465 HIS B 278 REMARK 465 HIS B 279 REMARK 465 HIS B 280 REMARK 465 HIS B 281 REMARK 465 HIS B 282 REMARK 465 HIS B 283 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 50 143.34 78.04 REMARK 500 ASP A 180 -179.57 -69.50 REMARK 500 ASN B 50 143.18 85.31 REMARK 500 ASP B 108 64.85 39.45 REMARK 500 SER B 182 -83.61 -65.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PLM A 1278 REMARK 610 PLM B 1278 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLM A1278 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLM B1278 DBREF 2W3Y A 1 277 UNP Q8GCR2 Q8GCR2_PECCC 1 277 DBREF 2W3Y B 1 277 UNP Q8GCR2 Q8GCR2_PECCC 1 277 SEQADV 2W3Y HIS A 278 UNP Q8GCR2 EXPRESSION TAG SEQADV 2W3Y HIS A 279 UNP Q8GCR2 EXPRESSION TAG SEQADV 2W3Y HIS A 280 UNP Q8GCR2 EXPRESSION TAG SEQADV 2W3Y HIS A 281 UNP Q8GCR2 EXPRESSION TAG SEQADV 2W3Y HIS A 282 UNP Q8GCR2 EXPRESSION TAG SEQADV 2W3Y HIS A 283 UNP Q8GCR2 EXPRESSION TAG SEQADV 2W3Y HIS B 278 UNP Q8GCR2 EXPRESSION TAG SEQADV 2W3Y HIS B 279 UNP Q8GCR2 EXPRESSION TAG SEQADV 2W3Y HIS B 280 UNP Q8GCR2 EXPRESSION TAG SEQADV 2W3Y HIS B 281 UNP Q8GCR2 EXPRESSION TAG SEQADV 2W3Y HIS B 282 UNP Q8GCR2 EXPRESSION TAG SEQADV 2W3Y HIS B 283 UNP Q8GCR2 EXPRESSION TAG SEQRES 1 A 283 MET LEU ASN GLU LYS ALA ILE GLN ASP VAL ASP LEU TYR SEQRES 2 A 283 PHE GLN ASN ILE HIS GLY PRO GLU GLY ARG LEU ALA SER SEQRES 3 A 283 ASN GLU THR PHE ASP ILE VAL PRO GLY LEU SER LYS ASP SEQRES 4 A 283 GLY ALA VAL GLN TYR GLN THR TYR GLN PHE ASN GLU ALA SEQRES 5 A 283 PRO LYS HIS LEU GLN LYS GLN VAL LYS ALA GLY ARG ILE SEQRES 6 A 283 LEU MET GLU ARG PHE VAL ALA VAL ALA SER ALA ALA VAL SEQRES 7 A 283 ASN LYS LYS ALA PRO SER ASN LYS GLU LYS TYR HIS TYR SEQRES 8 A 283 ASP ILE TRP LYS GLU VAL SER ASN GLN LEU ILE PRO ALA SEQRES 9 A 283 PHE PHE THR ASP PRO ILE LYS GLY GLU GLN ASN LEU ASN SEQRES 10 A 283 THR THR VAL LYS GLY VAL GLU VAL ALA LYS SER VAL ILE SEQRES 11 A 283 GLN PHE ALA GLY ASN VAL ILE ALA GLY ASN VAL THR GLY SEQRES 12 A 283 PHE ALA THR PHE LEU GLN ASN PHE GLY ASN GLY LEU SER SEQRES 13 A 283 ALA GLU MET ASN LYS THR GLN ALA ASN TYR ASN TYR LEU SEQRES 14 A 283 TYR ALA TYR SER THR HIS ASP LEU PHE GLN ASP THR SER SEQRES 15 A 283 GLY ASN VAL PHE TYR LYS PRO ARG PHE LEU ILE TYR GLY SEQRES 16 A 283 THR HIS PHE LYS GLN GLU GLN LYS LYS ILE ALA THR SER SEQRES 17 A 283 CYS ALA SER TYR GLN GLU VAL ASN LEU GLU PHE GLY VAL SEQRES 18 A 283 ASP THR VAL GLY GLY THR PHE ARG ILE GLU GLU TYR PHE SEQRES 19 A 283 SER ASN GLU THR PHE LYS LYS LYS VAL ASP ASN PHE LEU SEQRES 20 A 283 ASP LYS TYR GLU GLY LYS ALA ILE ASP ASP ALA ASP SER SEQRES 21 A 283 TYR PHE ASP ASP ILE PHE ASN GLY VAL LYS PRO ASN LYS SEQRES 22 A 283 ASN TYR VAL TYR HIS HIS HIS HIS HIS HIS SEQRES 1 B 283 MET LEU ASN GLU LYS ALA ILE GLN ASP VAL ASP LEU TYR SEQRES 2 B 283 PHE GLN ASN ILE HIS GLY PRO GLU GLY ARG LEU ALA SER SEQRES 3 B 283 ASN GLU THR PHE ASP ILE VAL PRO GLY LEU SER LYS ASP SEQRES 4 B 283 GLY ALA VAL GLN TYR GLN THR TYR GLN PHE ASN GLU ALA SEQRES 5 B 283 PRO LYS HIS LEU GLN LYS GLN VAL LYS ALA GLY ARG ILE SEQRES 6 B 283 LEU MET GLU ARG PHE VAL ALA VAL ALA SER ALA ALA VAL SEQRES 7 B 283 ASN LYS LYS ALA PRO SER ASN LYS GLU LYS TYR HIS TYR SEQRES 8 B 283 ASP ILE TRP LYS GLU VAL SER ASN GLN LEU ILE PRO ALA SEQRES 9 B 283 PHE PHE THR ASP PRO ILE LYS GLY GLU GLN ASN LEU ASN SEQRES 10 B 283 THR THR VAL LYS GLY VAL GLU VAL ALA LYS SER VAL ILE SEQRES 11 B 283 GLN PHE ALA GLY ASN VAL ILE ALA GLY ASN VAL THR GLY SEQRES 12 B 283 PHE ALA THR PHE LEU GLN ASN PHE GLY ASN GLY LEU SER SEQRES 13 B 283 ALA GLU MET ASN LYS THR GLN ALA ASN TYR ASN TYR LEU SEQRES 14 B 283 TYR ALA TYR SER THR HIS ASP LEU PHE GLN ASP THR SER SEQRES 15 B 283 GLY ASN VAL PHE TYR LYS PRO ARG PHE LEU ILE TYR GLY SEQRES 16 B 283 THR HIS PHE LYS GLN GLU GLN LYS LYS ILE ALA THR SER SEQRES 17 B 283 CYS ALA SER TYR GLN GLU VAL ASN LEU GLU PHE GLY VAL SEQRES 18 B 283 ASP THR VAL GLY GLY THR PHE ARG ILE GLU GLU TYR PHE SEQRES 19 B 283 SER ASN GLU THR PHE LYS LYS LYS VAL ASP ASN PHE LEU SEQRES 20 B 283 ASP LYS TYR GLU GLY LYS ALA ILE ASP ASP ALA ASP SER SEQRES 21 B 283 TYR PHE ASP ASP ILE PHE ASN GLY VAL LYS PRO ASN LYS SEQRES 22 B 283 ASN TYR VAL TYR HIS HIS HIS HIS HIS HIS HET PLM A1278 16 HET PLM B1278 16 HETNAM PLM PALMITIC ACID FORMUL 3 PLM 2(C16 H32 O2) FORMUL 4 HOH *362(H2 O) HELIX 1 1 GLN A 8 GLY A 19 1 12 HELIX 2 2 LEU A 56 ALA A 82 1 27 HELIX 3 3 ASN A 85 TYR A 89 5 5 HELIX 4 4 HIS A 90 PHE A 105 1 16 HELIX 5 5 GLU A 124 ASN A 135 1 12 HELIX 6 6 VAL A 141 ASN A 160 1 20 HELIX 7 7 LYS A 199 SER A 208 5 10 HELIX 8 8 ARG A 229 ASN A 236 1 8 HELIX 9 9 ASN A 236 GLU A 251 1 16 HELIX 10 10 ALA A 254 ALA A 258 5 5 HELIX 11 11 VAL B 10 GLY B 19 1 10 HELIX 12 12 PRO B 53 HIS B 55 5 3 HELIX 13 13 LEU B 56 ALA B 82 1 27 HELIX 14 14 ASN B 85 TYR B 89 5 5 HELIX 15 15 HIS B 90 PHE B 105 1 16 HELIX 16 16 GLU B 124 ASN B 135 1 12 HELIX 17 17 VAL B 141 ASN B 160 1 20 HELIX 18 18 LYS B 199 SER B 208 5 10 HELIX 19 19 ARG B 229 ASN B 236 1 8 HELIX 20 20 ASN B 236 GLU B 251 1 16 HELIX 21 21 ALA B 254 ALA B 258 5 5 SHEET 1 AA 6 LEU A 36 SER A 37 0 SHEET 2 AA 6 GLY A 40 PHE A 49 -1 O GLY A 40 N SER A 37 SHEET 3 AA 6 TYR A 166 GLN A 179 1 O ASN A 167 N ALA A 41 SHEET 4 AA 6 VAL A 185 PHE A 198 -1 O PHE A 186 N PHE A 178 SHEET 5 AA 6 GLU A 214 PHE A 228 -1 O ASP A 222 N GLY A 195 SHEET 6 AA 6 PHE A 106 LYS A 121 -1 O THR A 107 N THR A 227 SHEET 1 AB 3 LEU A 36 SER A 37 0 SHEET 2 AB 3 GLY A 40 PHE A 49 -1 O GLY A 40 N SER A 37 SHEET 3 AB 3 PHE A 262 PHE A 266 1 O PHE A 262 N THR A 46 SHEET 1 AC 2 VAL A 136 ILE A 137 0 SHEET 2 AC 2 LYS A 270 PRO A 271 -1 O LYS A 270 N ILE A 137 SHEET 1 BA 6 LEU B 36 SER B 37 0 SHEET 2 BA 6 GLY B 40 PHE B 49 -1 O GLY B 40 N SER B 37 SHEET 3 BA 6 TYR B 166 GLN B 179 1 O ASN B 167 N ALA B 41 SHEET 4 BA 6 VAL B 185 PHE B 198 -1 O PHE B 186 N PHE B 178 SHEET 5 BA 6 GLU B 214 PHE B 228 -1 O ASP B 222 N GLY B 195 SHEET 6 BA 6 PHE B 106 LYS B 121 -1 O THR B 107 N THR B 227 SHEET 1 BB 3 LEU B 36 SER B 37 0 SHEET 2 BB 3 GLY B 40 PHE B 49 -1 O GLY B 40 N SER B 37 SHEET 3 BB 3 PHE B 262 PHE B 266 1 O PHE B 262 N THR B 46 SHEET 1 BC 2 VAL B 136 ILE B 137 0 SHEET 2 BC 2 LYS B 270 PRO B 271 -1 O LYS B 270 N ILE B 137 LINK SG CYS A 209 C1 PLM A1278 1555 1555 1.62 LINK SG CYS B 209 C1 PLM B1278 1555 1555 1.62 SITE 1 AC1 5 LEU A 148 TYR A 170 ILE A 205 ALA A 206 SITE 2 AC1 5 CYS A 209 SITE 1 AC2 6 ALA B 133 LEU B 148 TYR B 194 ILE B 205 SITE 2 AC2 6 ALA B 206 CYS B 209 CRYST1 69.560 86.715 91.457 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014376 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011532 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010934 0.00000